These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62 related articles for article (PubMed ID: 11812568)
1. HIV-vaccine research takes one step forward. and one step back. Senior K Lancet; 2002 Jan; 359(9302):235. PubMed ID: 11812568 [No Abstract] [Full Text] [Related]
2. One step forwards, one step back. Lifson JD; Martin MA Nature; 2002 Jan; 415(6869):272-3. PubMed ID: 11796990 [No Abstract] [Full Text] [Related]
5. Relative importance and functional role of genetic elements targeted for a live attenuated AIDS vaccine. Lang SM; Desrosiers RC Antibiot Chemother (1971); 1996; 48():92-9. PubMed ID: 8726510 [No Abstract] [Full Text] [Related]
6. AIDS/HIV. Developing an AIDS vaccine: need, uncertainty, hope. Emini EA; Koff WC Science; 2004 Jun; 304(5679):1913-4. PubMed ID: 15218131 [No Abstract] [Full Text] [Related]
7. Prime-boost strategies in DNA vaccines. Dale CJ; Thomson S; De Rose R; Ranasinghe C; Medveczky CJ; Pamungkas J; Boyle DB; Ramshaw IA; Kent SJ Methods Mol Med; 2006; 127():171-97. PubMed ID: 16988455 [TBL] [Abstract][Full Text] [Related]
8. Current strategies and limitations of HIV vaccines. Kawalekar OU; Shedlock DJ; Weiner DB Curr Opin Investig Drugs; 2010 Feb; 11(2):192-202. PubMed ID: 20112169 [TBL] [Abstract][Full Text] [Related]
9. Cure of HIV infection: is the long wait over? Shearer WT J Allergy Clin Immunol; 2014 Jul; 134(1):20-2. PubMed ID: 25117800 [No Abstract] [Full Text] [Related]
10. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine. Bhardwaj N; Walker BD Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710 [No Abstract] [Full Text] [Related]
11. Viral evolution in macaques coinfected with CCR5- and CXCR4-tropic SHIVs in the presence or absence of vaccine-elicited anti-CCR5 SHIV neutralizing antibodies. Burke B; Derby NR; Kraft Z; Saunders CJ; Dai C; Llewellyn N; Zharkikh I; Vojtech L; Zhu T; Srivastava IK; Barnett SW; Stamatatos L Virology; 2006 Nov; 355(2):138-51. PubMed ID: 16920175 [TBL] [Abstract][Full Text] [Related]
12. Development of a novel rhesus macaque model with an infectious R5 simian-human immunodeficiency virus encoding HIV-1 CRF08_BC env. Huang L; Kusagawa S; Zeng H; Yang G; Sun B; Miura T; Yang R J Med Primatol; 2014 Feb; 43(1):11-21. PubMed ID: 24020838 [TBL] [Abstract][Full Text] [Related]
13. DNA vaccination of macaques by a full genome HIV-1 plasmid which produces noninfectious virus particles. Akahata W; Ido E; Shimada T; Katsuyama K; Yamamoto H; Uesaka H; Ui M; Kuwata T; Takahashi H; Hayami M Virology; 2000 Sep; 275(1):116-24. PubMed ID: 11017793 [TBL] [Abstract][Full Text] [Related]
14. Preclinical studies on immunogenicity of the HIV-1 p17-based synthetic peptide AT20-KLH. Fiorentini S; Marini E; Bozzo L; Trainini L; Saadoune L; Avolio M; Pontillo A; Bonfanti C; Sarmientos P; Caruso A Biopolymers; 2004; 76(4):334-43. PubMed ID: 15386266 [TBL] [Abstract][Full Text] [Related]
15. Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins. Mascola JR; Sambor A; Beaudry K; Santra S; Welcher B; Louder MK; Vancott TC; Huang Y; Chakrabarti BK; Kong WP; Yang ZY; Xu L; Montefiori DC; Nabel GJ; Letvin NL J Virol; 2005 Jan; 79(2):771-9. PubMed ID: 15613305 [TBL] [Abstract][Full Text] [Related]